Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

87.99 +7.28 (+9.02%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
AI Revolutionizes Professional Services: A New Era for Doctors, Lawyers, and Consultants
As of October 1, 2025, Artificial Intelligence (AI) has transcended its nascent stages, becoming an indispensable force in high-value professional tasks across medicine, law, and consulting. This... 
Via MarketMinute
Topics Artificial Intelligence
Tempus AI (TEM) Stock Is Rising Wednesday: What's Going On?
Shares of Tempus AI Inc (NASDAQ: TEM) are trading higher Wednesday, potentially building on momentum from last week given the lack of company-specific news. Here's what investors need to know. 
Via Benzinga
Topics Artificial Intelligence
Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density
From Ambry Genetics
Via Business Wire
Affirm Holdings, Oklo, Tempus AI Are Among Top 10 Large Cap Losers Last Week (Sep. 22- Sep. 26): Are The Others In Your Portfolio?
These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio? 
Via Benzinga
Topics Artificial Intelligence
3 Healthcare Stocks Using AI to Drive Growth
AI is reshaping healthcare by improving outcomes and easing burnout. See how three companies are leading this transformation 
Via MarketBeat
Topics Artificial Intelligence
What Are 2 Great Tech Stocks to Buy Right Now?
These two tech stocks could deliver big returns for investors willing to hold for the long term. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
7 Analysts Have This To Say About Tempus AI
Tempus AI (NASDAQ: TEM) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings,... 
Via Benzinga
Topics Artificial Intelligence
Why Tempus AI Stock Is Plunging This Week
When a well-known growth investor decides to trim her position in a stock, investors sit up and take note. 
Via The Motley Fool
Topics Artificial Intelligence ETFs
Cathie Wood Makes Trading Blitz: Buys Alibaba Stock Woth $11 Million, Dumps AMD And This AI Stock
On Wednesday Sept. 24, 2025, Cathie Wood-led Ark Invest purchased nearly $11 million worth of Alibaba stock while selling shares of AMD and Tempus AI. 
Via Benzinga
Topics Artificial Intelligence
Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead
Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They also made other key trades. 
Via Benzinga
Topics Artificial Intelligence
IBD 50's Tempus AI Hits Record High On Yet Another FDA Clearance
The company is focusing on RNA sequencing as a means of assisting with drug development. 
Via Investor's Business Daily
Topics Artificial Intelligence Intellectual Property
Tempus AI (TEM) Stock Is Rising Monday: What's Going On?
Tempus AI shares are trading higher Monday morning. The company announced it has received U.S. Food and Drug Administration 510(k) clearance for its RNA-based Tempus xR IVD device. 
Via Benzinga
Topics Artificial Intelligence
3 Big Short Interest Names with Bullish Setups
HIMS, DLO, and TEM combine high short interest with bullish chart setups, creating strong breakout potential as market momentum stays hot. 
Via MarketBeat
Topics Artificial Intelligence
Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device
From Tempus AI, Inc.
Via Business Wire
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%
On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and buying shares of Brera Holdings PLC (NASDAQ:BREA), 
Via Benzinga
Topics Artificial Intelligence
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NASDAQ:CRSP),(NASDAQ:BNTX),(NYSE:BMY) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Cathie Wood's Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI
On Tuesday, Cathie Wood-led Ark Invest executed significant trades, including buying shares of Advanced Micro Devices Inc. (NASDAQ:AMD) and Bullish Inc. (NYSE:BLSH), while selling shares o 
Via Benzinga
What's Going On With Tempus AI Stock Monday?
Tempus AI stock is trading marginally lower on Monday. Recent bullish sentiment follows last Thursday's announcement that Tempus AI received 510(k) clearance from the FDA. 
Via Benzinga
Topics Artificial Intelligence
Cathie Wood's Ark Pivots: Sells Tempus AI After FDA Win, Loads Up On Amazon, Figma And This Trendy Crypto Stock
Cathie Wood-led Ark Invest sold shares of Tempus AI, bought Bullish, Amazon, and Figma. The moves align with recent achievements and advancements of the companies. 
Via Benzinga
Topics Artificial Intelligence
Why Tempus AI Stock Soared Nearly 14% Higher Today
The AI heathcare tech specialist is about to put another product on the market. 
Via The Motley Fool
Topics Artificial Intelligence
Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging
Tempus AI's Tempus Pixel received FDA clearance for cardiac imaging updates, adding T1/T2 maps to enhance MR image analysis and diagnosis precision. 
Via Benzinga
Topics Artificial Intelligence
Tempus AI Surges, Flirting With A Profit-Taking Zone, On A Fresh FDA Move
Shares jumped into a profit-taking zone Thursday after the FDA cleared its updated cardiac-imaging platform. 
Via Investor's Business Daily
Topics Artificial Intelligence
Maze Therapeutics, Opendoor Technologies, Oxford Industries, VNET Group And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device
From Tempus AI, Inc.
Via Business Wire
Why Are Stock Market Investors Talking About TempusAI Stock?
Artificial intelligence is the hottest investing trend of 2025. 
Via The Motley Fool
Topics Artificial Intelligence
Stock Market Investors Want to Know: What's Going on With TempusAI Stock?
Revenue growth is soaring for TempusAI, and that has investors excited. 
Via The Motley Fool
Cathie Wood's Ark Dumps $2.1 Million Of This Hot AI Stock Despite Recent Acquisition Boost
On Tuesday, Cathie Wood-led Ark Invest sold shares of Tempus AI Inc (NASDAQ: TEM) through ARK Genomic Revolution ETF (ARKG) and ARK Innovation ETF (ARKK) totaling $2.1 million. This follows Tempus AI's... 
Via Benzinga
Topics Artificial Intelligence ETFs
Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer
From Tempus AI, Inc.
Via Business Wire
TEMPUS AI INC (NASDAQ:TEM) Excels on Minervini Trend Template with High Growth Momentum
Tempus AI (TEM) excels with a perfect technical rating, accelerating revenue growth of 89.57%, and strong earnings momentum, fitting the high-growth Minervini Trend Template. 
Via Chartmill
Topics Artificial Intelligence
Northwestern Medicine Becomes First Health System to Integrate Tempus’ Generative AI Co-Pilot, David, Into Its EHR Platform
From Tempus AI, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.